Skip to main content

Peer Review reports

From: Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva

Original Submission
22 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Sep 2022 Reviewed Reviewer Report
19 Sep 2022 Reviewed Reviewer Report - Sonal Priya Bhansali
4 Aug 2023 Author responded Author comments - Rose Marino
Resubmission - Version 3
4 Aug 2023 Submitted Manuscript version 3
17 Aug 2023 Reviewed Reviewer Report
18 Oct 2023 Author responded Author comments - Rose Marino
Resubmission - Version 4
18 Oct 2023 Submitted Manuscript version 4
18 Oct 2023 Author responded Author comments - Rose Marino
Resubmission - Version 5
18 Oct 2023 Submitted Manuscript version 5
Publishing
24 Oct 2023 Editorially accepted
13 Nov 2023 Article published 10.1186/s12874-023-02080-7

You can find further information about peer review here.

Back to article page